
Precede Biosciences
Developer of a liquid biopsy platform designed to provide unprecedented resolution into disease-defining biology from a simple blood test. The company's platform profiles circulating chromatin and the...
Valuation
$210M
Latest known
Share Price
N/A
Total Raised
$132M
Last Round
N/A